Pazopanib: An antiangiogenic drug in perspective

Keyphrases

• Pazopanib 100%
• Antiangiogenic Agents 100%
• Diarrhea 33%
• Safety Profile 33%
• Nausea 33%
• Hypertension 33%
• Mechanism of Action 33%
• Solid Tumors 33%
• Angiogenesis 33%
• Monotherapy 33%
• Hair Depigmentation 33%
• Angiogenic Pathway 33%
• Renal Cancer 33%
• Pre-clinical and Clinical Trials 33%
• Tyrosine Kinase Inhibitor 33%
• Synergistic Agents 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Pazopanib 100%
• Angiogenesis Inhibitor 100%
• Diarrhea 33%
• Solid Malignant Neoplasm 33%
• Nausea 33%
• Clinical Trial 33%
• Side Effect 33%
• Kidney Cancer 33%
• Monotherapy 33%
• Depigmentation 33%
• Protein Tyrosine Kinase Inhibitor 33%